(Q73449530)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675110%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Response of metastatic breast cancer to trastuzumab? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675110%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

main subject

metastatic breast cancer

1 reference

D M Barnes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675110%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D W Miles

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675110%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675110%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675110%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675110%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

9199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675110%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

160-161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675110%20AND%20SRC:MED&resulttype=core&format=json

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900430-4

7 January 2021

Using HER2 to choose chemotherapy in breast cancer: is it ready for the clinic?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900430-4

7 January 2021

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900430-4

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900430-4

7 January 2021

First MAb approved for treatment of metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900430-4

7 January 2021

Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900430-4

7 January 2021

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900430-4

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900430-4

7 January 2021

HER-2/neu testing comes of age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900430-4

7 January 2021

Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900430-4

7 January 2021

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900430-4

7 January 2021

10.1016/S0140-6736(99)00430-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675110%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference